 Amicus Therapeutics, Inc. NASDAQ:FOLD Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Andrew Faughnan - Senior Director, IR Bradley Campbell - CEO, President Director Sebastien Martel - Chief Business Officer Jeffrey Castelli - Chief Development Officer Daphne Quimi - CFO Conference Call Participants Anupam Rama - JPMorgan Chase Co. Ritu Baral - Cowen and Company Joseph Schwartz - SVB Securities Dae Gon Ha - Stifel Zhiqiang Shu - Berenberg Ellie Merle - UBS Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Second Quarter 2022 Financial Results Conference Call and Webcast. Operator Instructions. 